VAIDYA SANE AYUR LAB LTD
- P/E
- 17.1x
- 52-week range
- 147 – 335
- ROE
- 12%
- ROCE
- 15%
- Sector
- Healthcare Equipment & Supplies
- Industry
- Medical Equipment & Supplies
- Listed on
- NSE SME
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Medical Equipment & Supplies: 25 companies →VAIDYA SANE AYUR LAB LTD against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)17.1 against a typical 26.9: cheaper than most peers (1st = cheapest).5th of 25
- Sales growth+18.8% against a typical +21.5% from a year earlier.11th of 18
- Profit growth+300% against a typical +13.4% from a year earlier.1st of 16
- Share price, 3 months−16.1% against a typical −6.4%.16th of 23
Latest announcements
Exchange filings and their impact on the company.
- Madhavbaug signed a research MoU with Parul University with no near-term revenue commitment.
Vaidya Sane Ayurved Laboratories (Madhavbaug) has signed a Memorandum of Understanding dated October 9, 2026 with Parul Institute of Ayurved, Parul University. The MoU covers collaborative research, clinical validation, Ayurvedic formulation and nutraceutical development, training and potential technology transfer. The company said the MoU itself creates no financial commitment and specific projects will need separate agreements, so it builds a long-term research pipeline rather than near-term revenue.
Research by Minerva Capital Research Solutions
Our research team's work on VAIDYA SANE AYUR LAB LTDAlso covered in
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 15 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 5 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 1 Aug 2025 | Fund Raising/Other business matters | To consider Fund Raising and other business matters |
| 22 May 2025 | Financial Results | MADHAVBAUG : 22-May-2025 : The Company has informed the Exchange that a Board meeting to be held on May 12, 2025 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 22, 2025, To consider and approve the financial results for the period ended March 31, 2025 |
| 12 May 2025 | Financial Results | To consider and approve the financial results for the period ended March 31, 2025 |
| 11 Nov 2024 | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 46 | 54 | 51 | 48 | 42 | 48 | 50 | 57 |
| Expenses | 41 | 50 | 48 | 46 | 36 | 40 | 41 | 50 |
| Operating Profit | 4 | 4 | 3 | 2 | 6 | 9 | 9 | 7 |
| OPM % | 9% | 7% | 5% | 3.8% | 14% | 18% | 17% | 12% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 |
| Profit before tax | 4 | 3 | 2 | 1 | 5 | 5 | 6 | 4 |
| Tax % | 27% | 23% | 25% | 37% | 21% | 34% | 25% | 4% |
| Net Profit | 3 | 2 | 1 | 1 | 4 | 3 | 5 | 4 |
| EPS in Rs | 2.6 | 1.99 | 1.12 | 0.76 | 3.58 | 3.21 | 4.59 | 3.96 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 3%
- TTM
- 19%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 23%
- TTM
- 12%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −19%
- TTM
- —
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 10%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Prices are delayed and for information only. Nothing on this page is investment advice.